: We reveal a noncanonical Notch pathway for activating Notch target genes, ISC genes, and PD-L1 in CRC. This finding explains the immune escape of CRCSCs and indicates a potential group that may benefit from immune checkpoint inhibitors. Epigenetic drugs for reversing stem-like features of CRC should also be investigated.
No takes yet. Share an insight, caveat, or question.
Liao et al. (2020) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: